BRS HIVEC

The COMBAT BRS delivers heated chemotherapy, HIVEC (Hyperthermic Intra-VEsical Chemotherapy), to optimise the chemotherapy treatment for NMIBC patients. 

The COMBAT BRS is a closed, conductive, recirculation system with accurate temperature control that ensures homogenous heated drug distribution.

HIVEC real world datea shows promising results for reducing recurrence and progression rates in certain patient groups. 867 patients are currently in randomised controlled HIVEC trials. Results from these trials are expected to be consistent with the evidence being seen in the real world data published to date.